Overview

The Lipid Homeostasis and Neurobiology in Aging and Dementias Laboratory, which is led by Takahisa Kanekiyo, M.D., Ph.D., is part of the Department of Neuroscience on Mayo Clinic's Florida campus. The lab studies the pathogenic pathways of aging and age-related neurodegenerative diseases. Investigations in the lab span the breadth of different cell types in the brain and probe the depths of lipid homeostasis.

By dry weight, lipids make up half of the human brain. Lipids are a class of fatty organic compounds. They are one of the four classes of macromolecules found in living things.

Examples of lipids within the human body include:

  • Fats.
  • Fat-soluble vitamins, such as vitamins A and K.
  • Hormones.
  • Sterols, such as cholesterol.
  • Phospholipids, the primary component of cell membranes.

Lipids serve various roles in the human body. For these reasons, proper trafficking and processing of lipids in the body, especially in the brain, are critical to human health and homeostasis.

Alzheimer's disease, one of many different age-related dementias, is believed to have a diverse set of causes and corresponding risk factors. The greatest risk factor is age.

Genetic risk factors play a role in early-onset and late-onset forms of Alzheimer's disease. Apolipoprotein E (APOE) is the greatest genetic risk factor for the late-onset form of this disease. ATP-binding cassette transporter A7 (ABCA7) is another strong genetic risk factor for late-onset Alzheimer's disease. Given that both APOE and ABCA7 are involved in lipid homeostasis, Dr. Kanekiyo and his team investigate the intricate relationship between lipid homeostasis and neurobiology within the scope of aging and neurodegeneration.

The Lipid Homeostasis and Neurobiology in Aging and Dementias Lab uses many research tools and models to reach these goals:

  • Further understand the mechanisms of healthy and pathological aging in the brain.
  • Characterize lipid homeostasis and metabolism across nearly every cell type in the brain.
  • Develop effective therapies for dementias such as Alzheimer's disease.

Beyond research, Dr. Kanekiyo and his team also seek to inspire scientific curiosity from all people through rigorous yet compassionate mentorship. They also seek to advance science through numerous synergistic collaborations within and beyond Mayo Clinic.